BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17699387)

  • 1. Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy.
    Gutiérrez E; González E; Hernández E; Morales E; Martínez MA; Usera G; Praga M
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):51-7. PubMed ID: 17699387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute kidney injury in immunoglobulin A nephropathy: potential role of macroscopic hematuria and acute tubulointerstitial injury.
    Kveder R; Lindic J; Ales A; Kovac D; Vizjak A; Ferluga D
    Ther Apher Dial; 2009 Aug; 13(4):273-7. PubMed ID: 19695058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of acute renal failure in IgA nephropathy.
    Wen YK; Chen ML
    Ren Fail; 2010 May; 32(4):428-33. PubMed ID: 20446779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute reversible renal failure with macroscopic haematuria in IgA nephropathy.
    Delclaux C; Jacquot C; Callard P; Kleinknecht D
    Nephrol Dial Transplant; 1993; 8(3):195-9. PubMed ID: 8385283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible acute renal failure from gross haematuria due to glomerulonephritis: not only in IgA nephropathy and not associated with intratubular obstruction.
    Fogazzi GB; Imbasciati E; Moroni G; Scalia A; Mihatsch MJ; Ponticelli C
    Nephrol Dial Transplant; 1995; 10(5):624-9. PubMed ID: 7566573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological features of acute tubular necrosis in native kidneys and long-term renal function.
    Abdulkader RC; Libório AB; Malheiros DM
    Ren Fail; 2008; 30(7):667-73. PubMed ID: 18704814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute renal failure in IgA nephropathy.
    Packham DK; Hewitson TD; Yan HD; Elliott CE; Nicholls K; Becker GJ
    Clin Nephrol; 1994 Dec; 42(6):349-53. PubMed ID: 7882597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute renal failure in IgA nephropathy: aggravation by gross hematuria due to anticoagulant treatment.
    August C; Atzeni A; Köster L; Heidenreich S; Lang D
    J Nephrol; 2002; 15(6):709-12. PubMed ID: 12495289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress, macrophage infiltration and CD163 expression are determinants of long-term renal outcome in macrohematuria-induced acute kidney injury of IgA nephropathy.
    Gutiérrez E; Egido J; Rubio-Navarro A; Buendía I; Blanco Colio LM; Toldos O; Manzarbeitia F; de Lorenzo A; Sanchez R; Ortiz A; Praga M; Moreno JA
    Nephron Clin Pract; 2012; 121(1-2):c42-53. PubMed ID: 23095372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution on the correlation between morphometric parameters gained from the renal cortex and renal function in IgA nephritis.
    Mackensen-Haen S; Eissele R; Bohle A
    Lab Invest; 1988 Aug; 59(2):239-44. PubMed ID: 3404975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of recovery of renal function on long-term mortality after coronary artery bypass grafting.
    Mehta RH; Honeycutt E; Patel UD; Lopes RD; Shaw LK; Glower DD; Harrington RA; Califf RM; Sketch MH
    Am J Cardiol; 2010 Dec; 106(12):1728-34. PubMed ID: 21126617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predicting progression of IgA nephropathies.
    Coppo R; D'Amico G
    J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of gadolinium in patients with stage 3 and 4 renal failure.
    Ergün I; Keven K; Uruç I; Ekmekçi Y; Canbakan B; Erden I; Karatan O
    Nephrol Dial Transplant; 2006 Mar; 21(3):697-700. PubMed ID: 16326736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute renal failure in the course of IgA nephropathy in a 16-year-old boy].
    Bilińska W; Rogowska-Kalisz A; Nowicki M
    Pol Merkur Lekarski; 2003 Apr; 14(82):340-1. PubMed ID: 12868197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
    Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.
    Espinosa M; Ortega R; Gómez-Carrasco JM; López-Rubio F; López-Andreu M; López-Oliva MO; Aljama P
    Nephrol Dial Transplant; 2009 Mar; 24(3):886-91. PubMed ID: 18842673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.